Navigation Links
Dr. William Brody, President of the Salk Institute for Biological Studies, Appointed to GenVault's Board of Directors
Date:11/4/2009

CARLSBAD, Calif., Nov. 4 /PRNewswire/ -- GenVault Corporation (Carlsbad, CA) today announces that William Brody, M.D., Ph.D., has joined its Board of Directors. Dr. Brody, the Irwin Jacobs Presidential Chair of the Salk Institute, is an acclaimed physician-scientist and university leader. Prior to joining the Salk Institute, Dr. Brody served as president of The Johns Hopkins University. He is a member of the National Academy of Engineering and the Institute of Medicine, and is renowned for his academic achievements and his contributions to the field of biomedical engineering. Further, Dr. Brody co-founded three medical device companies and holds two U.S. patents in the field of medical imaging.

"We are all excited to welcome Dr. Brody to our Board of Directors and are extremely privileged to work with such a high caliber and accomplished individual," said Dr. David Wellis, President and CEO of GenVault Corporation. "The impressive depth of academic, engineering and medical experience and national and international credibility that Dr. Brody brings with him will be key in guiding our strategic focus as GenVault continues its expansion from biobanking into the genomic transport and analysis markets," continued Dr. Wellis.

Dr. Brody commented, "In this era of explosive growth for genomic analysis and genetic testing, the number of DNA and RNA samples stored, transported and analyzed is increasing exponentially. GenVault's products and technologies help researchers keep pace with this increase and also reduce the cost, complexity and waste associated with existing sample management methods. I look forward to working with GenVault as we develop and bring to market further innovative and sustainable sample management solutions for the life science and clinical marketplaces," said Dr. Brody.

Dr. Brody received his B.S. and M.S. degrees in electrical engineering from the Massachusetts Institute of Technology. He received his
'/>"/>

SOURCE GenVault Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology news :

1. NSF awards Williams funding for high-speed imaging faciltity
2. National Institutes of Health award Williams professor $217,710 research grant
3. 2 genes influence social behavior, visual-spatial performance in people with Williams syndrome
4. AIUM presents 2009 William J. Fry Memorial Lecture award
5. Presidents of Iceland, Bangladesh to discuss global climate change in New Orleans
6. Beginning scientists receive presidential awards
7. President honors mentors of scientists and engineers
8. IEEE-USA commends president for asking Congress to double support for critical research
9. Presidents science adviser to address IEEE International Homeland Security Conference
10. New book tutors future presidents and public on science behind the headlines
11. The Science Coalitions 10 questions for the presidential debate
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/11/2014)... have explored two different ways that allow unprecedented ... the formation of oxygen molecules in photosynthesis. The ... journal Nature Communications . , "The new ... for water oxidation, which are key components for ... of solar energy in fuels like hydrogen, ethanol ...
(Date:7/11/2014)... under the normal circumstances, astrocytes participate in ... environment, and exhibit therapeutic and repairing effects ... studies have found that nerve cells differentiated ... have reduced viability, which produces influences on ... Kailuan General Hospital, Hebei United University, China ...
(Date:7/10/2014)... In Santa Fe, Albuquerque, and other major cities in ... watered with treated municipal wastewater rather than precious potable ... more than 40% of all golf courses receive treated ... courses. , Additionally, golf courses and homeowners alike ... nutrient in fertilizer is nitrate. A New Mexico State ...
Breaking Biology News(10 mins):Molecular snapshots of oxygen formation in photosynthesis 2'Tailored' water -- the latest in lawn care 2
... non-native mussels in the Great Lakes has caused ... two of the planet,s largest freshwater lakes, according ... The blitzkrieg advance of two closely related species ... of their life-supporting algae, resulting in a remarkable ...
... 2011 A natural hormone known to inhibit aging can ... researchers have demonstrated. Scientists led by Dr. Makoto Kuro-o, ... hormone Klotho suppressed both renal fibrosis a common complication ... The findings are available online in the Journal of ...
... warming may be the greatest challenge of the present generation. ... the average citizen often wonders what he or she can ... FROM GERMANY,S SUCCESS IN HARNESSING CLEAN ENERGY" (Prometheus Books, $19) ... in the making veteran science and technology journalist Bob ...
Cached Biology News:Invasive mussels causing massive ecological changes in Great Lakes 2Invasive mussels causing massive ecological changes in Great Lakes 3Anti-aging hormone Klotho inhibits renal fibrosis, cancer growth 2Switching to solar 2
(Date:7/11/2014)... 11, 2014 Research and Markets  has ... Market - Global Industry Analysis, Size, Share, Growth, Trends ... http://photos.prnewswire.com/prnh/20130307/600769 ... (either DNA or RNA) into cells. This technology helps ... cells and protein metabolism by affecting the nuclear genes. ...
(Date:7/11/2014)... AZ (PRWEB) July 11, 2014 ... device company specializing in the soft tissue reconstruction ... All-Suture Anchor System for surgeries involving the shoulder ... fixation through a novel, inserter-controlled deployment method. The ... to partial deployment, anchor pull-out, or anchor displacement ...
(Date:7/10/2014)... Terascala, the industry leader in HPC ... former vice president of product management for Flexera Software, ... marketing. Terascala’s software when combined with leading compute and ... performance and most reliable solutions for processing big data. ... expansion and broaden its product portfolio. His leadership in ...
(Date:7/10/2014)... July 10, 2014 Senior supply chain ... professional associations, addressed the challenges of “Reducing Cost, Lead ... Industries” through strategic sourcing. Describing the partnership of the ... Supply Chain Management Institute ( SCMI) of the ... June 24 at the Kroc Institute of Peace and ...
Breaking Biology Technology:International Transfection Technology Market - Industry Analysis, Size, Share, Growth, Trends and Forecast to 2019 2Cayenne Medical Launches SureLock™ All-Suture Anchor System for Shoulder and Extremity Surgery 2Cayenne Medical Launches SureLock™ All-Suture Anchor System for Shoulder and Extremity Surgery 3Terascala Expands Executive Team 2Terascala Expands Executive Team 3Biotech & Biopharm Supply Chain Management Executives Launch BSMA in San Diego 2Biotech & Biopharm Supply Chain Management Executives Launch BSMA in San Diego 3Biotech & Biopharm Supply Chain Management Executives Launch BSMA in San Diego 4
... of Convertible Preferred Stock -, DALLAS, Jan. ... announced today that it has executed agreements,for $2.7 ... into agreements,with institutional and accredited investors to purchase ... the Company,s Series A Convertible,Preferred Stock. This equity ...
... Healionics Corporation, a,provider of tissue regeneration and ... it has raised $1.7 million,in a Series A ... Carl Lombardi, former CEO of SpaceLabs Medical and ... & Rejuvenation Center., "We are pleased to ...
... in cash at year end; no equity financings expected ... disease programs to continue in,2008; latest data for all ... - Expansion of research and development investment ... lysosomal diseases in 2008, CRANBURY, N.J., Jan. 29 ...
Cached Biology Technology:Access Pharmaceuticals Announces $2.7 Million New Equity 2Access Pharmaceuticals Announces $2.7 Million New Equity 3Healionics Corporation Completes Series A Financing 2Amicus Therapeutics Announces Fourth Quarter and Full Year 2007 Financial Results & Program Advancements 2Amicus Therapeutics Announces Fourth Quarter and Full Year 2007 Financial Results & Program Advancements 3Amicus Therapeutics Announces Fourth Quarter and Full Year 2007 Financial Results & Program Advancements 4Amicus Therapeutics Announces Fourth Quarter and Full Year 2007 Financial Results & Program Advancements 5Amicus Therapeutics Announces Fourth Quarter and Full Year 2007 Financial Results & Program Advancements 6Amicus Therapeutics Announces Fourth Quarter and Full Year 2007 Financial Results & Program Advancements 7Amicus Therapeutics Announces Fourth Quarter and Full Year 2007 Financial Results & Program Advancements 8Amicus Therapeutics Announces Fourth Quarter and Full Year 2007 Financial Results & Program Advancements 9Amicus Therapeutics Announces Fourth Quarter and Full Year 2007 Financial Results & Program Advancements 10Amicus Therapeutics Announces Fourth Quarter and Full Year 2007 Financial Results & Program Advancements 11Amicus Therapeutics Announces Fourth Quarter and Full Year 2007 Financial Results & Program Advancements 12Amicus Therapeutics Announces Fourth Quarter and Full Year 2007 Financial Results & Program Advancements 13Amicus Therapeutics Announces Fourth Quarter and Full Year 2007 Financial Results & Program Advancements 14